Business Description
Shanghai Allist Pharmaceuticals Co Ltd
ISIN : CNE100005XJ7
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1092.05 | |||||
Equity-to-Asset | 0.92 | |||||
Interest Coverage | 1754.3 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 39.57 | |||||
Beneish M-Score | -1.57 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 857.9 | |||||
3-Year FCF Growth Rate | 50.6 | |||||
3-Year Book Growth Rate | 29.1 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 90.26 | |||||
9-Day RSI | 83.35 | |||||
14-Day RSI | 77.42 | |||||
6-1 Month Momentum % | 30.63 | |||||
12-1 Month Momentum % | 59.24 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 8.69 | |||||
Quick Ratio | 8.5 | |||||
Cash Ratio | 6.91 | |||||
Days Inventory | 253.41 | |||||
Days Sales Outstanding | 40.72 | |||||
Days Payable | 194.52 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -7.7 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 96.21 | |||||
Operating Margin % | 26.08 | |||||
Net Margin % | 30.04 | |||||
FCF Margin % | 26.48 | |||||
ROE % | 14.68 | |||||
ROA % | 13.69 | |||||
ROIC % | 32.34 | |||||
ROC (Joel Greenblatt) % | 75.7 | |||||
ROCE % | 15.03 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 52.49 | |||||
PE Ratio without NRI | 55.47 | |||||
Price-to-Owner-Earnings | 66.67 | |||||
PS Ratio | 15.82 | |||||
PB Ratio | 7 | |||||
Price-to-Tangible-Book | 7.17 | |||||
Price-to-Free-Cash-Flow | 60.58 | |||||
Price-to-Operating-Cash-Flow | 49.88 | |||||
EV-to-EBIT | 38.1 | |||||
EV-to-EBITDA | 38.1 | |||||
EV-to-Revenue | 11.72 | |||||
EV-to-FCF | 43.15 | |||||
Price-to-Graham-Number | 4.2 | |||||
Price-to-Net-Current-Asset-Value | 10.18 | |||||
Price-to-Net-Cash | 13.25 | |||||
Earnings Yield (Greenblatt) % | 2.62 | |||||
FCF Yield % | 1.68 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Shanghai Allist Pharmaceuticals Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 1,621.087 | ||
EPS (TTM) (Â¥) | 1.08 | ||
Beta | 1.71 | ||
Volatility % | 48.31 | ||
14-Day RSI | 77.42 | ||
14-Day ATR (Â¥) | 2.223565 | ||
20-Day SMA (Â¥) | 47.1795 | ||
12-1 Month Momentum % | 59.24 | ||
52-Week Range (Â¥) | 22.16 - 56.69 | ||
Shares Outstanding (Mil) | 450 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Shanghai Allist Pharmaceuticals Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Shanghai Allist Pharmaceuticals Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Shanghai Allist Pharmaceuticals Co Ltd Frequently Asked Questions
What is Shanghai Allist Pharmaceuticals Co Ltd(SHSE:688578)'s stock price today?
When is next earnings date of Shanghai Allist Pharmaceuticals Co Ltd(SHSE:688578)?
Does Shanghai Allist Pharmaceuticals Co Ltd(SHSE:688578) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |